FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Douglas Reding

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Physiology

Postmenopause

Living Beings

Geographic Areas

United States

Objects

Diet

Co-author Network

Publications

TOP 3
Paul F Pinsky; Douglas Reding; Amanda Black; E David Crawford; Robert Grubb; Anthony Miller; Howard L Parnes; Gerald Andriole
Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Kathryn L Taylor; Timothy R Church; Kimberly M Davis; David L Dawson; Sara Edmond; Scott P Kelly; Gheorghe Luta; Jerome E Mabie; Anthony B Miller; Larry R Muenz; Douglas Reding; Thomas L Riley
Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.
Robert E Schoen; Joel L Weissfeld; Patrick Wright; Lance A Yokochi; Gerald L Andriole; Christine D Berg; Robert S Bresalier; Saundra S Buys; Danielle M Carrick; Timothy Church; E David Crawford; Mona N Fouad; John K Gohagan; Claudine Isaacs; Grant Izmirlian; Christine Cole Johnson; Barnett S Kramer; Adeyinka O Laiyemo; Anthony B Miller; Barbara O'Brien; Paul F Pinsky; Philip C Prorok; Mark P Purdue; Douglas Reding; Thomas L Riley
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Douglas Reding (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Paul F Pinsky; Douglas Reding; Amanda Black; E David Crawford; Robert Grubb; Anthony Miller; Howard L Parnes; Gerald Andriole
Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Cancer epidemiology 2012;36(6):e401-6.
2012: Kathryn L Taylor; Timothy R Church; Kimberly M Davis; David L Dawson; Sara Edmond; Scott P Kelly; Gheorghe Luta; Jerome E Mabie; Anthony B Miller; Larry R Muenz; Douglas Reding; Thomas L Riley
Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(22):2768-75.
2012: Robert E Schoen; Joel L Weissfeld; Patrick Wright; Lance A Yokochi; Gerald L Andriole; Christine D Berg; Robert S Bresalier; Saundra S Buys; Danielle M Carrick; Timothy Church; E David Crawford; Mona N Fouad; John K Gohagan; Claudine Isaacs; Grant Izmirlian; Christine Cole Johnson; Barnett S Kramer; Adeyinka O Laiyemo; Anthony B Miller; Barbara O'Brien; Paul F Pinsky; Philip C Prorok; Mark P Purdue; Douglas Reding; Thomas L Riley
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.
The New England journal of medicine 2012;366(25):2345-57.
2012: Joel L Weissfeld; Lance A Yokochi; Susan Yurgalevitch; Gerald L Andriole; Christine D Berg; Robert S Bresalier; Saundra S Buys; Timothy Church; E David Crawford; V Paul Doria-Rose; Mona N Fouad; Claudine Isaacs; Adeyinka O Laiyemo; Lois Lamerato; Paul F Pinsky; Philip C Prorok; Joshua Rathmell; Douglas Reding; Robert E Schoen
Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.
Journal of the National Cancer Institute 2012;104(4):280-9.
2012: Gerald L Andriole; Saundra S Buys; David Chia; Timothy R Church; Jonathan D Clapp; E David Crawford; Mona N Fouad; John K Gohagan; Robert L Grubb; Ann W Hsing; Claudine Isaacs; Grant Izmirlian; Barnett S Kramer; Paul A Kvale; Anthony B Miller; Barbara O'Brien; Paul F Pinsky; Philip C Prorok; Lawrence R Ragard; Joshua M Rathmell; Douglas Reding; Thomas L Riley; Joel L Weissfeld; Lance A Yokochi
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
Journal of the National Cancer Institute 2012;104(2):125-32.
2011: Alice J Sigurdson; Irene M Jones; Qingyi Wei; Xifeng Wu; Margaret R Spitz; Douglas A Stram; Myron D Gross; Wen-Yi Huang; Li-E Wang; Jian Gu; Cynthia B Thomas; Douglas Reding; Richard B Hayes; Neil E Caporaso
Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Carcinogenesis 2011;32(1):69-73.
2010: Robert T Greenlee; Bruce Kessel; Craig R Williams; Thomas L Riley; Lawrence R Ragard; Patricia Hartge; Saundra S Buys; Edward E Partridge; Douglas Reding
Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial.
American journal of obstetrics and gynecology 2010;202(4):373.e1-9.
2009: Lisa Mirabello; Wen-Yi Huang; Jason Y Y Wong; Nilanjan Chatterjee; Douglas Reding; E David Crawford; Immaculata DeVivo; Richard B Hayes; Sharon A Savage
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer.
Aging cell 2009;8(4):405-13.
2009: Jeannette M Schenk; Elio Riboli; Nilanjan Chatterjee; Michael F Leitzmann; Jiyoung Ahn; Demetrius Albanes; Douglas Reding; Yinghui Wang; Marlin Friesen; Richard Hayes; Ulrike Peters
Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(4):1227-31.
2009: Kyoung-Mu Lee; Daehee Kang; Sue Kyung Park; Sonja I Berndt; Douglas Reding; Nilanjan Chatterjee; STEPHEN CHANOCK; Wen-Yi Huang; Richard Hayes
Nitric oxide synthase gene polymorphisms and prostate cancer risk.
Carcinogenesis 2009;30(4):621-5.
2008: Robert L Grubb; Paul F Pinsky; Robert T Greenlee; Grant Izmirlian; Anthony B Miller; Thomas P Hickey; Thomas L Riley; Jerome E Mabie; David L Levin; David Chia; Barnett S Kramer; Douglas Reding; Timothy R Church; Lance A Yokochi; Paul A Kvale; Joel L Weissfeld; Donald A Urban; Saundra S Buys; Edward P Gelmann; Lawrence R Ragard; E David Crawford; Philip C Prorok; John K Gohagan; Christine D Berg; Gerald L Andriole
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
BJU international 2008;102(11):1524-30.
2008: Wen-Yi Huang; Richard Hayes; Ruth Pfeiffer; Raphael P Viscidi; Francis K Lee; Yun F Wang; Douglas Reding; Denise Whitby; John R Papp; Charles S Rabkin
Sexually transmissible infections and prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(9):2374-81.
2007: Sarah E Daugherty; Yin Yao Shugart; Elizabeth A Platz; MARGARET D FALLIN; William B Isaacs; Ruth M Pfeiffer; Robert Welch; Wen-Yi Huang; Douglas Reding; Richard Hayes
Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.
The Prostate 2007;67(14):1487-97.
2007: Daehee Kang; Kyoung-Mu Lee; Sue Kyung Park; Sonja I Berndt; Ulrike Peters; Douglas Reding; Nilanjan Chatterjee; Robert Welch; STEPHEN CHANOCK; Wen-Yi Huang; Richard Hayes
Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(8):1581-6.
2007: Daehee Kang; Kyoung-Mu Lee; Sue Kyung Park; Sonja I Berndt; Douglas Reding; Nilanjan Chatterjee; Robert Welch; STEPHEN CHANOCK; Wen-Yi Huang; Richard Hayes
Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(6):1303-5.
2007: Paul F Pinsky; Anthony B Miller; Barnett S Kramer; Timothy Church; Douglas Reding; Philip C Prorok; Edward P Gelmann; Robert E Schoen; Saundra S Buys; Richard Hayes; Christine D Berg
Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.
American journal of epidemiology 2007;165(8):874-81.
2007: Ulrike Peters; Charles B Foster; Nilanjan Chatterjee; Arthur Schatzkin; Douglas Reding; Gerald L Andriole; E David Crawford; Stefan Sturup; STEPHEN CHANOCK; Richard Hayes
Serum selenium and risk of prostate cancer-a nested case-control study.
The American journal of clinical nutrition 2007;85(1):209-17.
2006: James V Lacey; Mark H Greene; Saundra S Buys; Douglas Reding; Thomas L Riley; Christine D Berg; Richard M Fagerstrom; Patricia Hartge
Ovarian cancer screening in women with a family history of breast or ovarian cancer.
Obstetrics and gynecology 2006;108(5):1176-84.
2006: Mark E Sherman; James V Lacey; Saundra S Buys; Douglas Reding; Christine D Berg; Craig Williams; Patricia Hartge
Ovarian volume: determinants and associations with cancer among postmenopausal women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(8):1550-4.
2006: Daniel O Koralek; Ulrike Peters; Gerald L Andriole; Douglas Reding; Victoria A Kirsh; Amy F Subar; Arthur Schatzkin; Richard Hayes; Michael F Leitzmann
A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States).
Cancer causes & control : CCC 2006;17(6):783-91.
2006: E David Crawford; Paul F Pinsky; David Chia; Barnett S Kramer; Richard M Fagerstrom; Gerald L Andriole; Douglas Reding; Edward P Gelmann; David L Levin; John K Gohagan
Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial.
The Journal of urology 2006;175(4):1286-90; discussion 1290.
2006: Shih-Chen Chang; Regina G Ziegler; Barbara Dunn; Rachael Stolzenberg-Solomon; James V Lacey; Wen-Yi Huang; Arthur Schatzkin; Douglas Reding; Robert N Hoover; Patricia Hartge; Michael F Leitzmann
Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(2):334-41.
2005: Richard Hayes; Alice J Sigurdson; Lee Moore; Ulrike Peters; Wen-Yi Huang; Paul F Pinsky; Douglas Reding; Edward P Gelmann; Nathaniel Rothman; Ruth M Pfeiffer; Robert N Hoover; Christine D Berg
Methods for etiologic and early marker investigations in the PLCO trial.
Mutation research 2005;592(1-2):147-54.
2005: Amanda J Cross; Ulrike Peters; Victoria A Kirsh; Gerald L Andriole; Douglas Reding; Richard Hayes; Rashmi Sinha
A prospective study of meat and meat mutagens and prostate cancer risk.
Cancer research 2005;65(24):11779-84.
2005: Saundra S Buys; Edward E Partridge; Mark H Greene; Philip C Prorok; Douglas Reding; Thomas L Riley; Patricia Hartge; Richard M Fagerstrom; Lawrence R Ragard; David Chia; Grant Izmirlian; Mona N Fouad; Christine Cole Johnson; John K Gohagan
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
American journal of obstetrics and gynecology 2005;193(5):1630-9.
2005: Gerald L Andriole; David L Levin; E David Crawford; Edward P Gelmann; Paul F Pinsky; David Chia; Barnett S Kramer; Douglas Reding; Timothy R Church; Robert L Grubb; Grant Izmirlian; Lawrence R Ragard; Jonathan D Clapp; Philip C Prorok; John K Gohagan
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
Journal of the National Cancer Institute 2005;97(6):433-8.
2005: Paul F Pinsky; Pamela M Marcus; Barnett S Kramer; Matthew Freedman; Hrudaya Nath; Paul A Kvale; Douglas Reding
Diagnostic procedures after a positive spiral computed tomography lung carcinoma screen.
Cancer 2005;103(1):157-63.
2004: Gerald L Andriole; Douglas Reding; Richard Hayes; Philip C Prorok; John K Gohagan
The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise.
Urologic oncology 2004;22(4):358-61.
2004: D Kang; Gerald L Andriole; R C Van De Vooren; D Crawford; David Chia; Donald A Urban; Douglas Reding; Wen-Yi Huang; Richard Hayes
Risk behaviours and benign prostatic hyperplasia.
BJU international 2004;93(9):1241-5.
2003: Paul F Pinsky; Barnett S Kramer; Douglas Reding; Saundra S Buys
Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
American journal of epidemiology 2003;157(9):792-9.
2001: Edward P Gelmann; David Chia; Paul F Pinsky; Gerald L Andriole; E David Crawford; Douglas Reding; Richard Hayes; Barnett S Kramer; D L Woodrum; John K Gohagan; David L Levin
Relationship of demographic and clinical factors to free and total prostate-specific antigen.
Urology 2001;58(4):561-6.
2001: Amy F Subar; Regina G Ziegler; Frances E Thompson; Christine Cole Johnson; Joel L Weissfeld; Douglas Reding; K H Kavounis; Richard Hayes
Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires.
American journal of epidemiology 2001;153(4):404-9.
2000: Richard Hayes; Douglas Reding; William Kopp; Amy F Subar; N Bhat; Nathaniel Rothman; Neal Caporaso; Regina G Ziegler; Christine Cole Johnson; Joel L Weissfeld; Robert N Hoover; Patricia Hartge; C Palace; John K Gohagan
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.
Controlled clinical trials 2000;21(6 Suppl):349S-355S.
2000: Philip C Prorok; Gerald L Andriole; Robert S Bresalier; Saundra S Buys; David Chia; E David Crawford; Ronald Fogel; Edward P Gelmann; F Gilbert; Marsha Hasson; Richard Hayes; Christine Cole Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; Douglas Reding; W Rutt; Joel L Weissfeld; L Yokochi; John K Gohagan
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Controlled clinical trials 2000;21(6 Suppl):273S-309S.
2000: Patricia Hartge; Richard Hayes; Douglas Reding; Mark E Sherman; Philip C Prorok; Mark Schiffman; Saundra S Buys
Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial.
American journal of obstetrics and gynecology 2000;183(5):1232-7.